Skip Navigation


ToxSci Advance Access originally published online on November 16, 2006
Toxicological Sciences 2007 96(1):30-39; doi:10.1093/toxsci/kfl169
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
96/1/30    most recent
kfl169v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cavin, C.
Right arrow Articles by Schilter, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cavin, C.
Right arrow Articles by Schilter, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Reduction in Antioxidant Defenses may Contribute to Ochratoxin A Toxicity and Carcinogenicity

Christophe Cavin*,1, Thierry Delatour*, Maricel Marin-Kuan*, Daisy Holzhäuser*, Larry Higgins{dagger}, Claudine Bezençon*, Gabriela Guignard*, Sylviane Junod*, Janique Richoz-Payot*, Eric Gremaud*, John D. Hayes{dagger}, Sandra Nestler{ddagger}, Peter Mantle§ and Benoît Schilter*

* Quality and Safety Department, Nestlé Research Center, CH-1000 Lausanne 26, Switzerland {dagger} Biomedical Research Centre, University of Dundee, Dundee DD1 9SY, United Kingdom {ddagger} Nephro-Urology Unit, Institute of Child Health, University College London, London WC1E 1EH, United Kingdom § Department of Environmental Science and Technology, Imperial College London, London SW7 2AZ, United Kingdom

1 To whom correspondence should be addressed at Quality and Safety Department, Nestle Research Center, P.O. Box 44, Vers-chez-les Blanc, CH-1000 Lausanne 26, Switzerland. Fax: +41 21-785-85-53. E-mail: christophe.cavin{at}rdls.nestle.com.

Received July 26, 2006; accepted November 14, 2006


   Abstract

Ochratoxin A (OTA) is a renal carcinogen in rodents. Its human health significance is unclear. It likely depends upon the mechanism of carcinogenesis. In a previous microarray study a reduction in nuclear factor-erythroid 2 p45-related factor 2 (Nrf2)–dependent gene expression was observed in the kidney but not in the liver of rats fed OTA up to 12 months. Nrf2 regulates detoxification and antioxidant gene expression. The present report shows that OTA decreased the protein expression of several markers of the Nrf2-regulated gene battery in kidney in vivo indicating that the effects observed at mRNA level may be of biological significance. The OTA-mediated Nrf2 response could be reproduced in an NRK renal cell line and in primary hepatocyte cultures. In in vitro systems, an OTA-mediated inhibition of Nrf2 activity was demonstrated by electrophoretic mobility shift and Antioxidant Regulatory Element–driven luciferase reporter assays. The reduction of Nrf2-regulated gene expression resulted in oxidative DNA damage as evidenced by formation of abasic sites in vitro and confirmed in kidney in vivo. All OTA-mediated effects observed were prevented by pretreatment of cell cultures with inducers of Nrf2 activity. Our data suggest that reduction of cellular defense against oxidative stress by Nrf2 inhibition may be a plausible mechanism of OTA nephrotoxicity and carcinogenicity.

Key Words: mycotoxin; ochratoxin A; nuclear factor-erythroid 2 p45-related factor 2 (Nrf2); oxidative stress; nephrotoxicity; carcinogenicity.


This work was supported by the EU-Grant#QLK1-CT-2001-011614.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
C. Cavin, T. Delatour, M. Marin-Kuan, F. Fenaille, D. Holzhauser, G. Guignard, C. Bezencon, D. Piguet, V. Parisod, J. Richoz-Payot, et al.
Ochratoxin A-Mediated DNA and Protein Damage: Roles of Nitrosative and Oxidative Stresses
Toxicol. Sci., July 1, 2009; 110(1): 84 - 94.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. P. Grollman and B. Jelakovic
Role of Environmental Toxins in Endemic (Balkan) Nephropathy
J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2817 - 2823.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
E. Rached, G. C. Hard, K. Blumbach, K. Weber, R. Draheim, W. K. Lutz, S. Ozden, U. Steger, W. Dekant, and A. Mally
Ochratoxin A: 13-Week Oral Toxicity and Cell Proliferation in Male F344/N Rats
Toxicol. Sci., June 1, 2007; 97(2): 288 - 298.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Stemmer, H. Ellinger-Ziegelbauer, H.-J. Ahr, and D. R. Dietrich
Carcinogen-Specific Gene Expression Profiles in Short-term Treated Eker and Wild-type Rats Indicative of Pathways Involved in Renal Tumorigenesis
Cancer Res., May 1, 2007; 67(9): 4052 - 4068.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.